Funder
National Institute of General Medical Sciences
University of Connecticut
National Institutes of Health
National Cancer Institute
Reference76 articles.
1. Antisense oligonucleotides: an emerging area in drug discovery and development;Dhuri;J Clin Med,2020
2. Oligonucleotide therapeutics: from discovery and development to patentability;Moumne;Pharmaceutics,2022
3. Absorption, distribution, metabolism, and excretion of US Food and drug administration-approved antisense oligonucleotide drugs;Migliorati;Drug Metab Dispos,2022
4. Alnylam announces FDA approval of AMVUTTRA™ (vutrisiran), an RNAi therapeutic for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in Adults635;Alnylam Pharamceuticals;Business Wire,2022
5. Antisense drug discovery and development technology considered in a pharmacological context;Crooke;Biochem Pharmacol,2021
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献